Results

Total Results: 3,085 records

Showing results for "drugs".

221. Final Progress Report: Risk Analysis of Pediatric Chemotherapy Processes (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/shenep-report.pdf
     January 01, 2024 - keyed by our Protocol Office staff based on signed consents, before certain order sets or research drugs … distinguish between look-alike or (Only applicable routes sound-alike of administration specific drugs … Review the road map and/or protocol for the correct week and drugs. 2. Recalculate the dosage. … Reconstitute the appropriate amount of commonly used drugs. 2. … Sequence: 7 Calculate Dosage(s) Accomplished by: Pharmacist Story: Dosages are calculated on drugs

222. Section 2, Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-tech-specs.pdf
     June 15, 2018 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

223. Timely Antiobiotics for Children With Severe Sepesis or Septic Shock Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-sepsis-antibiotics-technical-specs.pdf
     August 01, 2014 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

224. Sampling, Weighting, and Synthetization Methodologies (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/data/SyH-DR-Sampling-Weighting-Synthetization-Methodologies-rev.pdf
     June 01, 2022 - Drugs may be associated with more than one therapeutic class. … This process was repeated for all drugs in that category. … Note that because the selection of synthetic drugs is probabilistic, each run of the SyH-DR produces … a different set of synthetic drugs. … Synthetic drug IDs were replaced by the names of the generic drugs.

225. AHRQ Views Blog Post: Rising to the Historic Challenges of COVID-19 | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/709.html
     April 01, 2020 - Each report examines a separate approach: opioids; nonopioid drugs; and nondrug treatments such as exercise … The report on opioids found small benefits from the use of those drugs, but also found that their use

226. Large-Scale Program To Reduce Heart Disease Risk Could Have Meaningful Health Benefits | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/857.html
     March 01, 2023 - Although there was concern that dexamethasone may reduce the effectiveness of the anti-clotting drugs … The authors suggested that study of this interaction is important as use of both drugs may be necessary

227. Comparative Health System Performance Initiative: National Bureau of Economic Research Center of Excellence | Agency for Healthcare Research and Quality
     www.ahrq.gov/chsp/about-chsp/centers/nber.html
     July 01, 2019 - Pricing Program on hospital–physician consolidation and on the outpatient administration of parenteral drugs … by hospital-owned facilities in three specialties in which parenteral drugs are frequently used .

228. The “Never Antibiotic” Diagnoses: Acute Bronchitis – Slides
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/ambulatory-care/bronchitis-slides.pptx
     September 01, 2022 - Drugs for cough. Med Lett Drugs Ther. 2018 Dec 17;60(1562):206-8.

229. Pharmacy Association Uses AHRQ Module to Teach Patients About Adverse Drug Interactions | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/coe0506.html
     October 01, 2014 - The module is also available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources

230. Antibiotic-Use-Commitment-Poster (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/antibiotic-use/safety/antibiotic-use-commitment-poster.docx
     November 01, 2019 - Antibiotics are lifesaving drugs but can have harmful side effects.

231. Final Progress Report: Pharmacist Technology for Nursing Home Resident Safety (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/lapane-report.pdf
     January 01, 2024 - , that these reports be “acted on,” and that each resident’s drug regimen be “free of unnecessary drugs … However, the most common precipitating factors are drugs (especially psychoactive drugs) and iatrogenic … Drugs Aging 2005;22(7):559-69. Hughes CM, Lapane KL. … Drugs Aging 2005;22(4):339-51. Hanlon JT, Scmader KE, Hughes C, Lapane KL, Swine C, Spinewine A. … Drugs Aging 1991; 5: 385-404. Lapane KL, Cameron K, Feinberg J.

232. Final Progress Report: Proactive Risk Reduction in Medication Prescribing in the Ambulatory Setting (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/field2-report.pdf
     January 01, 2024 - Scope Background Drugs are widely prescribed in the ambulatory setting. … Reducing frequency of MD not noticing drugs in the medical record through improvements to the EMR (probability … Monitoring of drugs with a narrow therapeutic range in ambulatory care. Am J Manag Care. … Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med.

233. Final Progress Report: Clinical importance of the drug interaction between statins and CYP3A inhibitors (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/strom-report.pdf
     January 01, 2024 - exposure.8, 15, 20 17, 21, 22-25 Of particular importance is the drug interaction between statins and drugs … CYP3A4 inhibitors prevent CYP3A4 isoenzymes from metabolizing other drugs (e.g., statin 3A4 substrates … , thyroid drugs, number of office visits, sCr measurements, ALT/AST measurements during the baseline … Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA. … Cardiovascular Drugs and Therapy. Dec 2005;19(6):403-414. 20. Holtzman CW, Wiggins BS, Spinler SA.

234. Falls Reduction Training Program
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/fallpxtoolkit/fallpxpresentation.pptx
     October 01, 2008 - urgency Lower-extremity weakness Gait and balance deficits Use of tranquilizers, sedative-hypnotic drugs … , or antihypertensive drugs Use of four or more prescription drugs Postural or orthostatic hypotension

235. Mental Health Alliance's Policy on Access to Medications Informed by AHRQ Research | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/cp30501.html
     October 01, 2014 - colleagues demonstrated to Medicaid that while restrictions placed on use of conventional anti-psychotic drugs

236. Figure 2: Framework for Stroke Rehabilitation | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/resources/vision/visfig2.html
     October 01, 2002 - Continuing with the example of stroke, anticoagulant drugs may be administered to break up blood clots

237. Final Progress Report: Transitional Care Medication Safety and Reducing Medical Liability: Closing the Chasm (pdf file)
     www.ahrq.gov/sites/default/files/2024-01/corbett-report.pdf
     January 01, 2024 - Fatal medication errors in the home, not involving alcohol or street drugs, increased 564% during the … National health spending in 2006: A year of change for prescription drugs. … A steep increase in domestic fatal medication errors with use of alcohol and/or street drugs.

238. Antibiotic Stewardship | Agency for Healthcare Research and Quality
     www.ahrq.gov/hai/tools/mrsa-prevention/toolkit/antibiotic-stewardship.html
     October 01, 2024 - Implementation of MRSA Prevention Fundamental Best Practices Antibiotics are life-saving drugs

239. Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/studies/index.html?page=45
     January 01, 2024 - Yeung K , Bloudek L , Ding Y AHRQ Author: Ding Y Value-based pricing of US prescription drugs … The study included 73 unique drugs, the sum of which accounted for $110.4 billion in annual U.S. drug … The researchers found that 11 unique drugs had multiple ICER-reported VBPs. 86.3% had observed net prices … reduction equated to an estimated total annual savings of $11.8 billion to $40.3 billion for the 73 drugs … Value-based pricing of US prescription drugs: estimated savings using reports from the Institute for

240. Library of PCOR Resources | Agency for Healthcare Research and Quality
     www.ahrq.gov/pcor/library-of-resources/index.html
     April 01, 2021 - Other records describe observational studies and programs providing access to investigational drugs … Canadian Agency for Drugs and Technologies in Health (CADTH) (Canada) Centre for Reviews and Dissemination